The domestic pharmaceutical equipment industry is growing against the trend, and its revenue may exceed 25 billion yuan in 2023

【Pharmaceutical Network Market Analysis】 The development of the pharmaceutical equipment industry is closely related
to the development of the pharmaceutical industry.
In recent years, in order to maintain their competitive advantage, Chinese pharmaceutical companies have continuously increased investment in research and development, bringing new increments
to the upstream pharmaceutical equipment market.
Data show that in recent years, the sales of the pharmaceutical equipment industry have shown a gradual improvement trend, and it is predicted that the sales of this market will reach 23.
216 billion yuan in 2022 and 25.
045 billion yuan
in 2023.
Analysts pointed out that in recent years, due to the continuous increase in residents' demand for drugs, and the country's further improvement of attention to drug quality, pharmaceutical companies' demand for new production lines and upgrades has been growing, and the sales of the pharmaceutical equipment industry have gradually increased
.
According to relevant statistics, from 2019 to 2021, the business revenue of China's pharmaceutical special equipment industry was 17.
270 billion yuan, 19.
787 billion yuan and 21.
387 billion yuan respectively, and it is predicted that its revenue will reach 23.
216 billion yuan in 2022 and 25.
045 billion yuan
in 2023.
At the same time, China's pharmaceutical equipment manufacturing enterprises have also shown a growth trend
in recent years.
Data show that from 2019 to 2021, the number of pharmaceutical special equipment enterprises above designated size in China is 124, 147 and 154 respectively, and it is predicted that it will reach 165 in 2022 and 176 by 2023
.
The domestic pharmaceutical equipment industry is achieving contrarian growth, and after decades of development, China's pharmaceutical equipment industry has grown a group of pharmaceutical equipment manufacturers
represented by Chutian Science and Technology, Dongfulong, etc.
, with strong research and development capabilities and competitiveness, and independent intellectual property rights.
Taking Dongfulong as an example, it has made great progress
in the pharmaceutical equipment sector.
It is reported that Dongfulong's business areas cover chemical small molecule drugs and biological macromolecule drugs
.
The products and solutions it provides basically cover the whole process of pharmaceutical production, including pharmaceutical API solutions (chemical drug synthesis, traditional Chinese medicine extraction, biological macromolecule stock solution) and preparation solutions (injections, solid dosages), inspection and packaging, mechanical and electrical installation, purification and air conditioning systems, document verification, automation and information software, plant design, etc
.
In the bioengineering sector, Chutian Technology has completed the whole industrial chain layout of "equipment + consumables", including stainless steel reactors, SUTs, microsphere fillers, chromatographic ultrafiltration, liquid distribution systems, etc.
, which will become an important driving force
for the company's performance growth in the future.
, the data shows that the company continues to increase investment in research and development, of which the company's R & D investment in the first three quarters of this year totaled about 375 million yuan, and the third quarter of R & D investment was nearly 150 million yuan, both continued to grow
significantly year-on-year.
For example, Chunguang Pharmaceutical Packaging has also increased its R&D investment in recent years, and the data shows that from 2019 to 2021 and from January to June 2022, its R&D investment was 5.
567 million yuan, 6.
4019 million yuan, 11.
48 million yuan and 6.
3501 million yuan respectively
.
At the same time, the company has also independently developed and accumulated a number of core technologies
such as high-speed cartoning technology of cartoning machine, sealing technology of filling machine, pattern benchmarking technology of filling machine, feeding technology of strip bag granular materials, sealing technology of aluminum-plastic blister packaging machine, etc.
Nowadays, some of China's leading pharmaceutical equipment enterprises have core technologies, the brand influence and product performance of industry enterprises are gradually forming, and the domestic substitution industry has become a trend
.
So what is the future development of the pharmaceutical equipment industry? The industry said that there is still more
room for growth.
On the one hand, national policies are vigorously supporting the high-quality development of the pharmaceutical equipment industry; On the other hand, the downstream pharmaceutical industry will have a stronger demand for pharmaceutical equipment
.
It is understood that in recent years, China has introduced a series of industrial policies to guide and support the development of the pharmaceutical equipment industry, creating a favorable environment
for the development of the industry.
For example, the "14th Five-Year Plan" pharmaceutical industry development plan clearly proposes to strengthen the research of key core technologies, carry out research around core equipment, and focus on improving high-end preparation production technology
.
At the same time, China's drug review reform, consistency evaluation, "procurement with quantity" and other policies have successively introduced in recent years, so that the pharmaceutical industry will carry out comprehensive industrial upgrading, thus making the upgrading of pharmaceutical equipment more urgent
.
Pharmaceutical enterprises will not only increase investment in pharmaceutical equipment, but also put forward higher requirements
for the performance, capacity, production efficiency, informatization, automation, intelligence and other aspects of pharmaceutical equipment.
In this context, what pharmaceutical equipment enterprises need to do is to continue to develop and innovate, so as to help pharmaceutical enterprises achieve high efficiency, cost reduction, energy-saving production and other related needs with more advanced pharmaceutical equipment, and achieve their own sustainable development
while promoting the upgrading of the pharmaceutical industry.
Disclaimer: Under no circumstances does the information or opinions expressed herein constitute investment advice
to anyone.